Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Athira Pharma has raised $90.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Athira Pharma's investors include Franklin Templeton, Janus Henderson Investors, Perceptive Advisors, TCG Crossover, Sofinnova Investments.
Athira Pharma is headquartered in Seattle, United States.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Athira Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Athira Pharma — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/athira-pharma. Accessed November 13, 2026.
VCBacked. (2025). Athira Pharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/athira-pharma
{{cite web |title=Athira Pharma — Funding & Investors |url=https://www.vcbacked.co/company/athira-pharma |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Athira Pharma? Request a listing update